Here's the live share price of Biocon along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Biocon has declined 1.78% CAGR. Over the past year, the corresponding return has been -3.23%.
Biocon’s current P/E of 124.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
| J B Chemicals & Pharmaceuticals | 0.74 | -2.61 | 10.72 | 11.58 | 12.56 | 23.16 | 30.35 |
Over the last one year, Biocon has declined 3.23% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Biocon has underperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 368.89 | 367.66 |
| 10 | 368.05 | 368.72 |
| 20 | 370.61 | 371.95 |
| 50 | 383.07 | 377.69 |
| 100 | 376.94 | 376.42 |
| 200 | 366.23 | 368.7 |
In the latest quarter, Biocon saw a drop in promoter holding to 44.92%, while DII stake increased to 24.16%, FII holding rose to 7.14%, and public shareholding moved down to 23.69% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,88,07,465 | 2.27 | 1,134.73 | |
| 1,39,69,697 | 2.36 | 550.27 | |
| 1,30,00,000 | 1.7 | 512.07 | |
| 1,20,44,737 | 1.27 | 474.44 | |
| 1,00,21,205 | 0.99 | 394.74 | |
| 62,69,066 | 1.34 | 246.94 | |
| 60,26,895 | 0.47 | 237.4 | |
| 58,62,280 | 1.8 | 230.92 | |
| 58,06,295 | 2.6 | 228.71 | |
| 38,00,000 | 1.47 | 144.02 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Feb 07, 2026, 9:43 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Jan 31, 2026, 1:53 AM IST | Biocon - Buyback Of Commercial Papers |
| Jan 29, 2026, 12:38 AM IST | Biocon - Intimation Of Record Date For Buy Back Of Listed Commercial Paper Issued By The Company |
| Jan 29, 2026, 12:27 AM IST | Biocon - Intimation Of Record Date For Buy Back Of Listed Commercial Paper Issued By The Company |
| Jan 28, 2026, 11:52 PM IST | Biocon - Notification To Stock Exchanges |
Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2242.60 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biocon is ₹373.90 as on Feb 09, 2026.
The Biocon is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Biocon is ₹60,605.74 Cr as on Feb 09, 2026.
Today’s highest and lowest price of Biocon are ₹375.10 and ₹366.45.
The 52-week high/low is the highest and lowest price at which Biocon stock has traded in the past 52-week or nearly a year. The 52-week high of Biocon is ₹424.95 and 52-week low of Biocon is ₹290.80 as on Feb 09, 2026.
The Biocon has shown returns of 2.38% over the past day, -3.43% for the past month, -1.64% over 3 months, -3.23% over 1 year, 16.3% across 3 years, and -1.78% over 5 years.
P/E ratio of and PB ratio of Biocon are 124.84 and 2.25 on Feb 09, 2026. While the company gives a dividend yield of 0.13 per annum.